openPR Logo
Press release

Global Postmenopausal Osteoporosis Therapeutics Market to Incur Steady Growth During 2015-2021

10-18-2018 08:21 AM CET | Health & Medicine

Press release from: Persistence Market Research

Global Postmenopausal Osteoporosis Therapeutics Market

Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The currently available technologies fail to cure postmenopausal osteoporosis completely and thus healthcare professionals prefer medicinal therapy for treatment of postmenopausal osteoporosis.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/5882

Considering the relation of age in postmenopausal osteoporosis, aging of population worldwide is the major factor that is increasing the morbidity rate of postmenopausal osteoporosis. Increasing prevalence of this condition and innovations in the corresponding drug market are major driving forces of the postmenopausal osteoporosis therapeutics market. While high standards for approval of any new product to launch into the market, competition from the emerging alternative technologies and intense competition from generics are restraining growth of this market. Mergers and acquisitions taking place in the market is one of the major restraining force of postmenopausal osteoporosis therapeutics market.

Based on the type of medicines used, postmenopausal osteoporosis therapeutics market is segmented as follows:

Bisphosphonates
Hormones
Strontium ranelate
Raloxifene
Denosumab
Others

Request TOC@ https://www.persistencemarketresearch.com/methodology/5882

Geographically, the global postmenopausal osteoporosis therapeutics market is segmented into:

North America
Europe
Asia Pacific
Rest of the World
Currently, North America dominates the postmenopausal osteoporosis therapeutics market and is closely followed by Europe. Asia-Pacific is a lucrative regional market for such drugs considering factors such as increasing healthcare spending and improving healthcare infrastructure. Gradual; development of the medical tourism industry in the region is also expected to further spur the growth of postmenopausal osteoporosis therapeutics market in Asia-Pacific. Some of the major companies contributing to the global postmenopausal osteoporosis therapeutics market are Eli Lilly, Pfizer, Inc., F. Hoffman La Roche, Procter & Gamble and Merck.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Postmenopausal Osteoporosis Therapeutics Market to Incur Steady Growth During 2015-2021 here

News-ID: 1311775 • Views:

More Releases from Persistence Market Research

Shear Balers Market Projected to Expand at 6.1% CAGR Through 2032 | Persistence Market Research
Shear Balers Market Projected to Expand at 6.1% CAGR Through 2032 | Persistence …
The global shear balers market is gaining significant traction as industries worldwide prioritize efficient management, sustainable recycling, and resource optimization. Valued at US$1.4 billion in 2025, the market is projected to reach US$2.1 billion by 2032, expanding at a steady CAGR of 6.1% during the forecast period. This growth reflects the rising adoption of advanced metal processing technologies and the increasing emphasis on circular economy practices across manufacturing, construction, and
Reverse Osmosis Pump Market Expected to Reach US$15.9 Billion by 2032, Reveals Persistence Market Research Report
Reverse Osmosis Pump Market Expected to Reach US$15.9 Billion by 2032, Reveals P …
The global reverse osmosis (RO) pump market is witnessing substantial growth as the demand for efficient water purification systems continues to escalate across industries, municipalities, and households. Valued at approximately US$8.6 billion in 2025, the market is projected to reach US$15.9 billion by 2032, expanding at a CAGR of 8.5% during the forecast period. This strong upward trajectory reflects the increasing global focus on water conservation, desalination, and sustainable water
Heat Pump Market Expected to Reach US$180.3 Billion by 2032, Reveals Persistence Market Research
Heat Pump Market Expected to Reach US$180.3 Billion by 2032, Reveals Persistence …
The global heat pump market is undergoing rapid transformation as industries and consumers increasingly shift toward energy-efficient and sustainable heating and cooling technologies. According to the latest report from Persistence Market Research, the global heat pump market size is estimated to be valued at US$87.4 billion in 2025 and is projected to reach US$180.3 billion by 2032, expanding at a strong CAGR of 10.9% during the forecast period (2025-2032). This
Precast Concrete Market Projected to Attain US$210.9 Billion by 2032, Reveals Persistence Market Research Analysis
Precast Concrete Market Projected to Attain US$210.9 Billion by 2032, Reveals Pe …
The global precast concrete market is entering a phase of transformative growth, driven by rapid urbanization, increasing infrastructure investments, and the global push toward sustainable and efficient construction practices. Valued at US$137.5 billion in 2025, the market is projected to reach US$210.9 billion by 2032, expanding at a CAGR of 6.3% between 2025 and 2032. Precast concrete - a high-strength construction material produced by casting concrete in reusable molds under

All 5 Releases


More Releases for Osteoporosis

Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period? The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate? The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss. View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss. The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample Although osteoporosis cannot be treated, it can be slowed down or
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related